Neurocrine Biosciences
NBIX
#1468
Rank
A$21.85 B
Marketcap
A$215.03
Share price
-0.03%
Change (1 day)
-0.86%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company